Annals of Surgical Oncology

, Volume 18, Issue 13, pp 3544–3550 | Cite as

Features Associated with Successful Recruitment of Diverse Patients onto Cancer Clinical Trials: Report from the American College of Surgeons Oncology Group

  • Kathleen M. Diehl
  • Erin M. Green
  • Armin Weinberg
  • Wayne A. Frederick
  • Dennis R. Holmes
  • Bettye Green
  • Arden Morris
  • Henry M. Kuerer
  • Robert A. Beltran
  • Jane Mendez
  • Venus Gines
  • David M. Ota
  • Heidi Nelson
  • Lisa A. Newman
Healthcare Policy and Outcomes



The clinical trials mechanism of standardized treatment and follow-up for cancer patients with similar stages and patterns of disease is the most powerful approach available for evaluating the efficacy of novel therapies, and clinical trial participation should protect against delivery of care variations associated with racial/ethnic identity and/or socioeconomic status. Unfortunately, disparities in clinical trial accrual persist, with African Americans (AA) and Hispanic/Latino Americans (HA) underrepresented in most studies.

Study Design

We evaluated the accrual patterns for 10 clinical trials conducted by the American College of Surgeons Oncology Group (ACOSOG) 1999–2009, and analyzed results by race/ethnicity as well as by study design.


Eight of 10 protocols were successful in recruiting AA and/or HA participants; three of four randomized trials were successful. Features that were present among all of the successfully recruiting protocols were: (1) studies designed to recruit patients with regional or advanced-stage disease (2 of 2 protocols); and (2) studies that involved some investigational systemic therapy (3 of 3 protocols).


AA and HA cancer patients can be successfully accrued onto randomized clinical trials, but study design affects recruitment patterns. Increased socioeconomic disadvantages observed within minority-ethnicity communities results in barriers to screening and more advanced cancer stage distribution. Improving cancer early detection is critical in the effort to eliminate outcome disparities but existing differences in disease burden results in diminished eligibility for early-stage cancer clinical trials among minority-ethnicity patients.


African American African American Cancer Clinical Trial Patient Navigator Clinical Trial Participation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Newman LA, Hurd T, Leitch M, Kuerer HM, Diehl K, Lucci A, et al. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. J Am Coll Surg. 2004;199:644–51.PubMedCrossRefGoogle Scholar
  2. 2.
    Newman LA, Lee CT, Parekh LP, Stewart AK, Thomas CR Jr, Beltran RA, et al. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Cancer. 2006;106:188–95.PubMedCrossRefGoogle Scholar
  3. 3.
    NIH Revitalization Act. Public Law 103-43, 1993.Google Scholar
  4. 4.
    Peterson ED, Lytle BL, Biswas MS, Coombs L. Willingness to participate in cardiac trials. Am J Geriatr Cardiol. 2004;13:11–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Beswick AD, Rees K, Griebsch I, Taylor FC, Burke M, West RR, et al. Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups. Health Technol Assess. 2004;8:iii–iv, ix–x, 1–152.Google Scholar
  6. 6.
    Bartlett C, Davey P, Dieppe P, Doyal L, Ebrahim S, Egger M. Women, older persons, and ethnic minorities: factors associated with their inclusion in randomised trials of statins 1990 to 2001. Heart. 2003;89:327–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002;162:1682–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Alvidrez J, Arean PA. Psychosocial treatment research with ethnic minority populations: ethical considerations in conducting clinical trials. Ethics Behav. 2002;12:103–16.PubMedCrossRefGoogle Scholar
  9. 9.
    Miskimen T, Marin H, Escobar J. Psychopharmacological research ethics: special issues affecting US ethnic minorities. Psychopharmacology (Berl). 2003;171:98–104.CrossRefGoogle Scholar
  10. 10.
    Miranda J, Nakamura R, Bernal G. Including ethnic minorities in mental health intervention research: a practical approach to a long-standing problem. Cult Med Psychiatry. 2003;27:467–86.PubMedCrossRefGoogle Scholar
  11. 11.
    Gifford AL, Cunningham WE, Heslin KC, Andersen RM, Nakazono T, Lieu DK, et al. Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med. 2002;346:1373–82.PubMedCrossRefGoogle Scholar
  12. 12.
    Hussain-Gambles M, Atkin K, Leese B. Why ethnic minority groups are under-represented in clinical trials: a review of the literature. Health Soc Care Community. 2004;12:382–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Leffall LD Jr, Organ CH Jr. Honorary/Sandoz Nutrition Lectureship. Ethics in research and surgical practice. Am J Surg. 1997;174:589–91.PubMedCrossRefGoogle Scholar
  14. 14.
    Leffall LD Jr. Ethics in surgical research. Surgery. 1998;123:603–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Betancourt JR. Cultural competence—marginal or mainstream movement? N Engl J Med. 2004;351:953–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Adams-Campbell LL, Ahaghotu C, Gaskins M, Dawkins FW, Smoot D, Polk OD, et al. Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol. 2004;22:730–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Simon MS, Du W, Flaherty L, Philip PA, Lorusso P, Miree C, et al. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol. 2004;22:2046–52.PubMedCrossRefGoogle Scholar
  18. 18.
    Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 1995;3:19–30.PubMedGoogle Scholar
  19. 19.
    Vargas RB, Ryan GW, Jackson CA, Rodriguez R, Freeman HP. Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. Cancer. 2008;113:426–33.PubMedCrossRefGoogle Scholar
  20. 20.
    McGinnis LS, Menck HR, Eyre HJ, Bland KI, Scott-Conner CE, Morrow M, et al. National Cancer Data Base survey of breast cancer management for patients from low income zip codes. Cancer. 2000;88:933–45.PubMedCrossRefGoogle Scholar
  21. 21.
    Stewart AK, Bland KI, McGinnis LS Jr, Morrow M, Eyre HJ. Clinical highlights from the National Cancer Data Base, 2000. CA Cancer J Clin. 2000;50:171–83.PubMedCrossRefGoogle Scholar
  22. 22.
    Leitch AM, Beitsch PD, McCall LM, Posther K, Newman LA, Herndon JE II, et al. Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. Am J Surg. 2005;190:539–42.PubMedCrossRefGoogle Scholar
  23. 23.
    U.S. Census Bureau, Population Division, Population Projections Branch. Maintained by Information and Research Services Internet Staff (Population Division). (March 18, 2004).
  24. 24.
    McKinnon J. The black population in the United States: March 2002. Current Population Reports, Series P20-541. Washington, DC: U.S. Census Bureau; 2003.Google Scholar
  25. 25.
    Ramirez RR, de La Cruz GP. The Hispanic population in the United States: March 2002. Current Population Reports, P20-545. Washington, DC: U.S. Census Bureau; 2002.Google Scholar

Copyright information

© Society of Surgical Oncology 2011

Authors and Affiliations

  • Kathleen M. Diehl
    • 1
  • Erin M. Green
    • 2
  • Armin Weinberg
    • 3
  • Wayne A. Frederick
    • 4
  • Dennis R. Holmes
    • 5
  • Bettye Green
    • 6
  • Arden Morris
    • 1
  • Henry M. Kuerer
    • 7
  • Robert A. Beltran
    • 8
  • Jane Mendez
    • 9
  • Venus Gines
    • 10
  • David M. Ota
    • 11
  • Heidi Nelson
    • 2
  • Lisa A. Newman
    • 1
  1. 1.Department of Surgery and Comprehensive Cancer CenterUniversity of MichiganAnn ArborUSA
  2. 2.Mayo ClinicRochesterUSA
  3. 3.Baylor Medical CollegeHoustonUSA
  4. 4.Howard UniversityWashingtonUSA
  5. 5.Department of Breast SurgeryUSC Norris Cancer CenterLos AngelesUSA
  6. 6.ACOSOG Patient Advocate CommitteeDurhamUSA
  7. 7.Department of Surgical OncologyUTMD Anderson Cancer CenterHoustonUSA
  8. 8.Latino Med Policy InstituteLos AlamitosUSA
  9. 9.School of Medicine, Department of SurgeryBoston UniversityBostonUSA
  10. 10.ACOSOG Special Populations CommitteeDurhamUSA
  11. 11.Department of SurgeryDuke UniversityDurhamUSA

Personalised recommendations